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Background: Dried fruits of Berberis crataegina (Berberidaceae) have been frequently consumed as food garniture
in Turkish cuisine, while its fruit paste has been used to increase stamina and in particular to prevent from
cardiovascular dysfunctions in Northeastern Black Sea region of Turkey. This study investigated this folkloric
information in order to explain the claimed healing effects as well as to evaluate possible risks.
Methods: Total phenolic, flavonoid and proanthocyanidin contents and antioxidant capacity of the methanolic fruit
extract were evaluated through several in vitro assays. The cytotoxic and genotoxic effects of B. crataegina fruit
extract were also assessed in both cervical cancer cell line (HeLa) and human peripheral blood lymphocytes.
Results: The extract showed protective effects against ferric-induced oxidative stress and had a relatively good
antioxidant activity. It also ameliorated the H2O2 mediated DNA damage in lymphocytes, suggesting the protective
effect against oxidative DNA damage.
Conclusion: The methanolic extract of B. crataegina fruits may be a potential antioxidant nutrient and also may
exert a protective role against lipid peroxidation as well as oxidative DNA damage.
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Berberis species (Berberidaceae) are known to exert
spasmolytic, cholagogue, analgesic, anti-inflammatory,
anxiolytic, antipsychotic, antidepressant, and potent sco-
licidal effects [1-3]. There are four naturally occurring
species of Berberis in Turkey. Among these species, B.
crataegina DC. and its hybrids are widely distributed
and its black fruits are often consumed as food, and used
as diuretic and expectorant. Moreover, the roots and
root barks of this plant have been used in Turkish folk
medicine against various ailments including jaundice,
hemorrhoids, dysuria and as febrifuges in feverish condi-
tions as well as tonic and appetizer [4,5]. On the other
hand, the red fruits of another species, B. vulgaris L.,
have been used as a garniture in Persian food culture* Correspondence: yesilada@yeditepe.edu.tr
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unless otherwise stated.owing to its color and mellow taste [2,6], while the
aqueous extract of barks is reported to be used to treat
rheumatism and fever in Azerbaijan folk medicine [5]
and Bulgaria [7].
Similar utilizations for the roots of several other Berberis
species have also been reported elsewhere. In Uzbekistan,
condensed aqueous extract of B. oblonga root is reported
to be prescribed for the effective treatment of lumbago
[8], while in Nepal, the condensed aqueous extract of B.
asiatica Roxb. root barks is reported to be used orally
against fever and in Pakistan powdered roots of B. lycium
Royle are used orally with milk to treat rheumatic and
muscular pains [5].
As summarized above, the underground parts of Berberis
species have been used particularly against inflammatory
disorders in worldwide traditional medicines, while the
fruits of Berberis species have frequently been used as food,
rather than for healing purposes. According to a recent
report, the fruit paste of B. crataegina has been used totral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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vascular dysfunctions in Northeastern Black Sea region of
Turkey [9].
Reactive oxygen species (ROS) and reactive nitrogen
species (RNS), either generated exogenously or produced
endogenously, are involved in a variety of biological phe-
nomena such as pathogenesis of many diseases, muta-
tion, carcinogenesis and aging [10,11]. Fortunately, there
are several defense mechanisms for protection against
these reactive molecules under physiological steady state
conditions. Among these various defense mechanisms,
the antioxidant system is extremely important due to its
direct removal of pro-oxidants and maximum protection
for biological sites [10]. Furthermore, it is important to
protect the balance between oxidative stress and antioxi-
dant defense mechanisms in order to prevent the adverse
effects generated by oxidative stress [12]. Scientific investi-
gations have demonstrated that phytochemicals are a great
source for antioxidants, particularly the phenolic compo-
nents, which have the structural requirements for free
radical scavenging activity [1,12,13]. Ethanolic extracts
of roots, twigs and leaves of B. vulgaris L. and also B.
croatica Horvat showed some radical scavenging activity
in correlation with the content of phenolic compounds
[1]. In another study, Hanachi et al. [14] showed that B.
vulgaris fruits exhibit antioxidant activity and have the
ability to reduce the cell viability in human liver cancer
cell line.
The present survey was aimed to evaluate the antioxi-
dant effects of the fruit paste of B. crataegina in order to
explain the claimed healing effects as well as to define the
possible risks. For this purpose, the in vitro antioxidant
potential of B. crataegina fruits extract was evaluated
through several chemical and biochemical assays, in-
cluding 2,2′-diphenyl-1-picrylhydrazyl (DPPH) radical-
scavenging activity, superoxide anion radical scavenging
activity, ferric reducing antioxidant power (FRAP), cupric
reducing antioxidant capacity (CUPRAC), β-carotene
bleaching, total antioxidant capacity (TOAC) and Trolox
equivalent antioxidant capacity (TEAC). Also, the cyto-
toxic and genotoxic effects of B. crataegina fruits extract
were investigated in both human cervival cancer cell line
(HeLa) and human peripheral blood lymphocytes. In
addition to these tests, the total contents of phenolic, fla-
vonoid and proanthocyanidin of the fruits were also
determined.
Material and methods
Preparation of fruit extract
The dried B. crataegina fruits (2 kg) were provided from
Bayburt province (Turkey) and authenticated by one of
the authors (E.Y.). A voucher specimen was deposited in
the Herbarium of Faculty of Pharmacy, Yeditepe Univer-
sity (YEF 10018). The fruits were washed, mashed in ablender with 500 mL of warm distilled water and freeze-
dried (Christ Alpha 2-4 LD). Then 200 g of dried fruit
sample were extracted twice with 50 mL of 80% metha-
nol (Sigma) at 45°C for 4 hours with continuous stirring.
The combined extract was filtered through a filter paper
and then was evaporated to dryness under reduced pres-
sure. Finally, the sticky residue was dissolved in distilled
water and freeze-dried [BCFE] (yield, 9.2%).
Phytochemical screening of the extract
The method previously described was used for deter-
mination of total phenolic content [15]. Accordingly,
20 μL of properly diluted BCFE sample were mixed with
Folin–Ciocalteu reagent (Sigma) and Na2CO3 (20%)
(Riedel de Hean). Then, samples were incubated at 45°C
for 30 minutes. At the end of this period, the absorbance
was measured at 765 nm by UV-Vis spectrophotometer
(Thermo, Evolution 300). Results were expressed as mg
gallic acid equivalents (GAE) per gram of dried extract.
For the determination of total flavonoid content,
500 μL of properly diluted BCFE sample were mixed
with 10% AlCl3 (Merck) and 1 M sodium acetate (Riedel
de Hean). Following the incubation period (30 minutes
at room temperature), the absorbance was recorded at
415 nm. Results were expressed as mg quercetin equiva-
lents (QE) per g of dried extract [13].
The total proanthocyanidin content of the BCFE sample
was measured by adding of 2.5 mL of vanillin (1%) (Fluka)
and 2.5 mL of 9 M HCl (Sigma) in methanol to properly
diluted extracts. After incubating at 30°C for 20 min, the
absorbance was measured at 500 nm. Total proanthocyani-
din content of samples was expressed as mg epigallocate-
chingallate equivalents (EGCG-E) per g of dry extract [13].
Measurement of in vitro antioxidant activity
DPPH radical-scavenging activity, superoxide anion radical
scavenging activity, FRAP, CUPRAC, β-carotene bleaching,
TOAC and TEAC were measured spectrophotometrically
by the methods previously described by Celep et al. [13].
In vitro cytotoxicity and genotoxicity studies
Treatment of human peripheral lymphocytes
The donor was a 30 years old woman (non-smoker) and
her health status was completely compatible with the
WHO guideline on the blood donor selection criteria.
Treatment procedure I Lymphocytes were isolated
from the whole blood by using LeucoSep® (greiner bio-
one) centrifuge tubes according to the instruction manual
provided by the manufacturer. Briefly, the anticoagulated
blood sample was poured into the Leucosep tube and
centrifuged for 10 min (1000xg). The lymphocytes ap-
peared at the interface between the plasma (top layer) and
separation medium (Ficoll, 1.077 g/ml). This enriched cell
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washed with 10 ml of phosphate-buffered saline (PBS),
and centrifuged for 10 min at 250 x g. Afterwards, 50 μL
aliquots of the cell (lymphocyte) suspension were dis-
pensed into micro centrifuge tubes (1x104-2x104 cells/
50 μL). 1 mL aliquots of BCFE (0.001, 0.005, 0.01, 0.05,
0.1, 0.2, 0.5, 1, 2, and 4 mg/mL) were added into related
micro-centrifuge tubes and incubated for 2 hours. Two
micro-centrifuge tubes were allocated as positive control
and treated with 50 μM and 100 μMH2O2 at the last 5 mi-
nutes of the incubation period. The micro-centrifuge tubes
were centrifuged at 250 g and the supernatants were dis-
carded. The DNA damage in lymphocytes was identified
by using the alkaline comet assay.
Treatment procedure II The same procedure described
above was applied with the following exception; the
micro-centrifuge tubes containing BCFE were treated
with 50 μM H2O2 at the last 5 minutes of the 2 hours
incubation period. Afterwards, the procedure proceeded
with centrifugation as was described above. The DNA
repair in lymphocytes was identified by using the alkaline
comet assay.
Comet assay
Preparation of the cells
The same comet assay procedure was used for both
HeLa cells and lymphocytes. The details of the procedure
were formerly described [16,17]. Briefly; 50 μL aliquots of
the cell suspension (1x104 - 2x104 HeLa cells or lympho-
cytes/50 μL) were mixed with 100 μL of low melting point
agarose (0.5% LMA) (Sigma) and dispensed onto the
microscope slides previously coated with normal melting
point agarose (1% NMA) (Sigma). The suspension spread
by using a coverslip and left on an ice-cold flat tray for
5 minutes. After removal of the cover slip, the slides were
immersed in lysing solution.
Lysing
The slides were immersed into formerly prepared cold
(4°C) lysing solution containing 2.5 M NaCl (Sigma),
100 mM Na2EDTA (Sigma), 10 mM Tris (Sigma), 1% so-
dium sarcosinate (Sigma), (pH 10) with 1% Triton-X 100
(Sigma) and 10% DMSO (Sigma) and left there for
1 hour, afterwards the slides were removed from the lysing
solution and drained.
Electrophoresis
The slides were placed in horizontal gel electrophoresis
tank containing the electrophoresis solution (1 mM
Na2EDTA and 300 mM NaOH, pH 13). Electrophoresis
was then conducted for 20 min by applying an electric
current of 25 V/300 mA to allow damaged DNA to mi-
grate from the nucleus toward the anode.Neutralization: The slides were then drained, placed
on tray and washed with three changes of neutralization
buffer (0.4 M Tris, pH 7.5) for 5 minutes each. The
slides were left to drain before staining.
Staining
The slides were stained with 50 μL (20 μg/mL) ethidium
bromide (Sigma) and covered with a coverslip. Then the
slides were viewed using a fluorescence microscope
(Leica DM1000) equipped with an excitation filter of
515-560 nm. A single scorer randomly selected and cap-
tured 100 cells using the Perceptive Instruments COMET
Assay IV analysis system. Tail % intensity was selected as
the image analysis parameter. Two slides were prepared
for each single sample. The results are given as the mean
of both slides.
Trypan blue viability test
The cell suspension (lymphocytes) was diluted (1:1) with
0.4% trypan blue solution (Sigma) and carefully filled the
hemocytometer (Improved Neubauer) chamber. The vi-
able (unstained) and non-viable cells (blue) were counted
under a microscope.
Treatment of HeLa cells
The HeLa cell line was cultured as a monolayer in an
appropriate tissue culture flask at 37°C with 5% CO2 in
F12 HAM containing 10% heat inactivated fetal bovine
serum (Sigma), 50 μg/mL penicillin (Biological Indus-
tries) and 50 μg/mL streptomycin (Biological Industries).
When cells approach confluence, they were removed
from the flask by trypsinization. After counting the cells,
the culture is seeded into two 24-well plates (5x104
cells/well) and incubated at 37°C with 5% CO2 for
24 hours. Afterwards, 1 mL aliquots of BCFE (0.001,
0.005, 0.01, 0.05, 0.1, 0.2, 0.5, 1, 2, and 4 mg/mL) were
added into related wells and incubated for 2 hours. Two
wells were allocated as positive control and treated with
50 μM and 100 μM H2O2 (Merck) at the last 5 minutes
of the incubation period. The cells were removed from
the wells by trypsinization and the supernatant was dis-
carded after centrifugation at 2500 rpm for 5 minutes.
The DNA damage in HeLa cells was identified by using
the alkaline comet assay.
In another set of 24-well plates, the HeLa cells were
exposed 24 hours to the equal concentrations of BCFE
by using the same procedure described above.
Neutral Red Uptake (NRU) cytotoxicity test
The HeLa cells were cultured as described above then
seeded into a 96-well microtiter plate (1x104 cells/well)
and incubated at 37°C with 5% CO2 for 24 hours. After-
wards, the culture medium was removed and the cells
were treated with 100 μl treatment medium containing
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(sodium dodecyl sulfate, SDS) (Merck). After 24 hours
of treatment period, medium were removed and the cells
were washed with 150 μl PBS (Thermo). Thereafter, PBS
was aspirated and the cells were incubated in 100 μl of
neutral red medium (Sigma) for additional 3 hours. After
this final incubation period, neutral red medium were
discarded and washed with 150 μl PBS. Finally 150 μl
ethanol (Sigma)/acetic acid (Sigma) (1% glacial acetic
acid, 50% ethanol, %49 H2O) solution were added to all
wells and the 96-well plate was shaken for 10 minutes
in a micro plate shaker. The absorption of the colored
solution was measured at 540 nm by a micro plate
reader (SpectraMax 190) and the related IC50 values
were computed [18].
Statistical evaluation
All of the results are expressed as the mean ± SD. For
in vivo data, the differences between the groups were
evaluated with Kruskal-Wallis analysis of variance and
comparisons between two independent groups were
made with the Mann-Whitney U-test. For the data of
the comet assay, the analysis of variance (ANOVA) was
used to determine whether there are any significant dif-
ferences between the means of the groups. The Dunnett
test was used as part of the ANOVA test to determine
whether means were different from mean of the control.
All statistical tests were performed with SPSS for Windows
Release 11. p < 0.05 was considered statistically significant.
Results and discussion
Phytochemical screening of the extract
Phenolic compounds are the major class of bioactive
components. Previous reports have shown that the fruits
of various Berberis species are rich in polyphenolic constit-
uents and eventually fruit extracts have shown to possess
potent free radical-scavenging activity [19-21] due to the
polyphenolic compound’s ability to act as hydrogen do-
nors, reducing agents and radical scavengers [1].
Flavonoids and proanthocyanidins are one of the
major polyphenolic constituents of plants because of the
radical scavenging ability conferred by their hydroxyl
groups at various positions; particularly of an ortho-
dihydroxy structure in their B ring [15]. A previous study
revealed that polyphenols can also prevent oxidative





BCFE 53.51 ± 3.62 27.42 ±
AResults were expressed as the mean of triplicates ± standard deviation (S.D.).
BTotal phenolic content was expressed as mg gallic acid equivalents (GAE) in 1 g dr
CTotal flavonoid content was expressed as mg quercetin equivalents (QE) in 1 g dri
DTotal proanthocyanidin content was expressed as mg epigallocathecin gallate equLimited numbers of studies have previously been re-
ported the phenolic contents of the fruits of Berberis
species, i.e. B. vulgaris, [23] while no report have been
found on the polyphenolics of B. crataegina fruits in a
reference survey. In present study, total phenolics, flavo-
noids and proanthocyanidins contents of 80% methano-
lic extracts of BCFE were evaluated and results were
expressed as mg gallic acid, quercetin and epigallocathe-
chingallate equivalents, respectively (Table 1).
In vitro antioxidant activity
Since free radicals are one of the main causes of oxida-
tive stress, the ability of BCFE on free radical scavenging
was assessed by DPPH, superoxide radical scavenging
and TEAC tests in this study [15]. As given in Table 2,
DPPH radical scavenging activity of BCFE was about
30% of reference substance BHT and superoxide radical
scavenging activity was about 2% of reference substance
gallic acid. These results indicate that BCFE does not
have a good activity against superoxide radicals but have
a relatively good activity against other stable radicals like
DPPH. On the other hand, Fe3+ and Cu2+ involve in the
formation of free radicals and the reduction of ferric as
well as cupric ions indicate another mechanism of anti-
oxidant potential [13]. As shown in Table 2, ferric redu-
cing power of BCFE was higher than that of reference
substance BHT and copper reducing activity was about
the 5.6% of ascorbic acid. These results indicate that
BCFE can prevent ferric induced oxidative stress effi-
ciently but not for copper. As an indicator of the preven-
tion of lipid peroxidation, β-carotene bleaching assay
demonstrated that BCFE to possess about 80% of activity
of reference substance BHT, suggesting a good activity
against lipid peroxidation (Table 2). Furthermore, total
antioxidant capacity of BCFE was about 8.6% of ascorbic
acid and 20% of Trolox, indicating a relatively good anti-
oxidant activity (Table 2).
In vitro evaluation of genotoxicity and cytotoxicity
The genotoxic potential of the BCFE in HeLa cells was
tested at concentrations lower than its IC50 value. Since
the DNA damaging potential of H2O2 is well known and
has been reported previously in several published studies
[16,17], H2O2 (50 and 100 μM) was used as a positive
control. The HeLa cells were treated with increasing





1.34 548 ± 19.7
ied extract ± S.D.
ed extract ± S.D.
ivalents (EGCG-E) in 1 g dried extract ± S.D.








BCFE 405 ± 11.6 9.04 ± 0.92 0.76 ± 0.03 56.3 ± 0.17 77 ± 2.2 86.69 ± 4.62 198 ± 5.6
BHT* 133 ± 6.4 3.02 ± 0.07 96 ± 2.6
Gallic acid 0.18 ± 0.01
AResults were expressed as the averages of triplicates ± standard deviation (S.D.), BIC50, expressed in μg/mL,
CIC50, expressed in mg/mL,
DFerric reducing
antioxidant power was expressed as mM FeSO4 equivalents in 1 g material,
ECopper reducing antioxidant capacity was expressed as mg ascorbic acid equivalents
in 1 g material, FThe results of β-carotene bleaching assay was given as % in 1 mg/mL extract or reference compound, GTotal antioxidant capacity was expressed
as mg ascorbic acid equivalents in 1 g material, HTrolox equivalent antioxidant capacity was expressed as μM Trolox equivalent in 1 g material, *Butylated
hydroxy toluene.
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identified by using the comet assay and expressed in
terms of tail % intensity. As shown in Figure 1, the mean
tail % intensity was significantly increased in each tested
concentrations with the exception of 0.05 mg/mL (p <
0.05) under the treatment duration of 2 hours. These re-
sults indicate a negative effect of BCFE on the DNA integ-
rity of HeLa cells. On the other hand, the mean tail %
intensity values were completely changed under the treat-
ment duration of 24 hours. The mean tail % intensity
value was sharply increased at the concentration of
0.05 mg/mL and even the mean tail % intensity value of
the positive control (50 μM H2O2) was exceeded at theFigure 1 The DNA integrity of HeLa cells treated with increasing
concentrations of BCFE for 2 hours. *The tail % intensity was
significantly increased when compared with the control (p < 0.05).
Black bars representing the positive controls.concentration of 4 mg/mL as shown in Figure 2. However,
the mean tail % intensity values determined for the con-
centrations of 0.001 and 0.01 mg/mL were decreased to
the control level. Apparently, the damaged DNA was
repaired in 24 hour. These results indicate an adaptive
cellular response in HeLa cells at these two concentra-
tions of BCFE.
The viability of lymphocytes varied between 93.75%
and 100% within the tested concentrations are shown in
Figure 3. The genotoxic effect of BCFE was determined
also in human peripheral blood lymphocytes. The DNA
damage started to occur at 2 mg/mL with a significantly
increased (p < 0.05) mean tail % intensity value. TheFigure 2 The DNA integrity of HeLa cells treated with increasing
concentrations of BCFE for 24 hours. *The tail % intensity was
significantly increased when compared with the control (p < 0.05).
Black bars representing the positive controls.
Figure 3 Dose-dependent effects of BCFE on the DNA integrity of human peripheral blood lymphocytes. The H2O2 (50 and 100 μM) treated
lymphocytes are the controls for the combined treatments (black bars). The white and black bars represent the mean tail % intensity values
determined after the treatment period of 2 hours. *Significantly different from the related control. The viability of lymphocytes varied between
93.75% and 100% within the tested concentrations.
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were not statistically different from the mean tail % in-
tensity value of the control. In other words, the DNA in-
tegrity of lymphocytes was not affected by BCFE at the
concentration of 1 mg/mL or lower.
Interestingly, the results obtained in HeLa cells and
lymphocytes were not comparable to each other. Al-
though, HeLa cells and lymphocytes were treated with
the same concentrations of BCFE for the same period of
time (2 hours), HeLa cells were more vulnerable to the
components in BCFE as shown in Figure 1. Apparently,Figure 4 The cytotoxic effects of BCFE and SDS (positive control). The IC50 vahuman peripheral blood lymphocytes are more resistant
to the in BCFE.
The influence of H2O2 (50 μM) on the DNA integrity
of lymphocytes treated with increasing concentrations of
BCFE was investigated within the study. Accordingly,
the DNA damage generated by 50 μM H2O2 was signifi-
cantly decreased in lymphocytes previously treated with
BCFE at concentrations of 0.001, 0.01, 0.05, 0.2, and
4 mg/mL (Figure 3). BCFE has clearly ameliorate the
H2O2 mediated DNA damage in lymphocytes at the
above mentioned concentrations. In other words, BCFElues of BCFE and SDS were 4.98 mg/mL and 0.055 mg/mL, respectively.
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protective effect might be a reflection of the induced
DNA repair or the antioxidant capacity of polyphenolic
compounds in BCFE [21]. On the other hand, the DNA
damage of lymphocytes was significantly induced with
BCFE at 4 mg/mL. In spite of this genotoxic effect at
4 mg/mL, the H2O2 (50 μM) induced oxidative DNA
damage was significantly reduced at the same extract
concentration.
The results obtained in NRU cytotoxicity tests were
used to identify the IC50 value of the BCFE in HeLa cells.
Accordingly, the computed IC50 values of BCFE and SDS
(positive control) were 4.98 mg/mL and 0.055 mg/mL, re-
spectively (Figure 4).
Conclusions
In conclusion, the present study has revealed that BCFE
possesses potent total antioxidant activity, scavenging
stable radicals like DPPH, prevent ferric induced oxida-
tive stress and has a good activity against lipid peroxida-
tion. Also, the BCFE can be a potent protective nutrient
against oxidative DNA damage. However, it should be
considered that the results of in vitro antioxidant assays
may sometimes conflict with the results obtained from
in vivo models. Therefore, in order to ascertain the role
of dietary antioxidants fully, in vivo tests are incredibly
necessary.
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